| ²é¿´: 2548 | »Ø¸´: 31 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
¡¾ÇóÖú/½»Á÷¡¿Çë½Ì´ïÈË£ºÏëÕÒ³öÁ½¸öϸ¾úÖвîÒì±í´ïµÄ»ùÒò£¬ÓÐʲô³ÉÊìÇÒ±ãÒ˵ķ½·¨£¿
|
|||
| ÏÖÓÐÁ½Öêϸ¾ú£¬ÔÝÃüÃûΪ1ºÍ2£¬ÆäÖÐ2¶ÔÓÚijÖÖ¿¹Äæ»·¾³¾ßÓиü¸ßµÄµÖ¿¹Á¦£¬ÏÖÔÚÏëÕÒ³öÔÚÕâÖÖ»·¾³ÏÂÁ½¸ö¾úÖê²îÒì±í´ïµÄ»ùÒò£¬²»ÖªÓÐʲô°ì·¨£¿ÆäÖоú1ÒѾÍê³ÉÁË»ùÒò×é²âÐò£¬¾ú2δ²âÐò£¬ÓÉÓÚ¾·ÑÓÐÏÞ£¬²»Ì«¿ÉÄܲÉÓÃÈ«»ùÒò×éоƬ·½·¨£¬Çë½Ì¸÷λ´ïÈË£¬ÓÐʲô¼È±ãÒËÓֱȽϳÉÊìµÄ·½·¨£¿²»Ê¤¸Ð¼¤£¡ |
» ²ÂÄãϲ»¶
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ºÊµÑéÆ÷²ÄµÄ ¡°ÎÚÁú¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ººÍʵÑé²ÄÁ쵀 ¡°¶·ÖǶ·Ó¡±
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ65È˻ظ´
µ°°×Öʼì²â£º¾«×¼·ÖÎö£¬½âËøÉúÎï·Ö×ÓµÄÃÜÂë
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑé֮СÊóʵÑ飺ÑϽ÷Éè¼Æ£¬½âÎöÉúÃü»úÖÆµÄÖØÒªÔØÌå
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®ÖØ½ðÊô¼ì²â£º¾«×¼É¸²é£¬ÊØ»¤½¡¿µÓë»·¾³µÄ·ÀÏß
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÍܲâÖØ½ðÊôÎÒ±³¹øÈýǧ¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÊóÌÓÈý´ÎÎÒ·¢ÈýƪSCI¡±
ÒѾÓÐ0È˻ظ´
ÄÉÃ×Á£¶È·ÖÎö
ÒѾÓÐ3È˻ظ´
ÁÖ¿ÆÔºÁÖ»¯ËùÕÐÊÕ²ÄÁÏÓ뻯¹¤×¨ÒµË¶Ê¿£¬×ø±êÄϾ©
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Çë½ÌÓлú»úÖÆ´ïÈË£¬Ò»¸ö·´Ó¦»úÀí~~~~
ÒѾÓÐ8È˻ظ´
½ð±ÒÇë½Ì´ïÈËÒ»Çó·½²îµÄÎÊÌ⣬ʮ·Ö׿±£¬Òª¿¼ÊÔÁË£¡
ÒѾÓÐ16È˻ظ´
¹òÇó¸ÅÂÊÂÛ´ïÈËÎÊÌâÓйØversionµÄÎÊÌ⣡£¡£¡
ÒѾÓÐ4È˻ظ´
ÓйØ2012cscÉêÇëµÄ¼¸¸öÎÊÌ⣬Çë´ïÈËÓ»Ô¾»Ø´ð
ÒѾÓÐ21È˻ظ´
Çë½ÌÓоÑéµÄÓлú´ïÈË¡ª¡ª¹ýÖù·ÖÀëÎÊÌâ
ÒѾÓÐ10È˻ظ´
´óÇåÔç·¢¸öÇóÖúÌû£¬Çó΢ÉúÎï´ïÈË´ÓÐÎ̬Éϼø±ðÒ»ÏÂÕâÊÇʲô¾ú
ÒѾÓÐ19È˻ظ´
ÇëÎÊÉêÇë±±ÃÀÁôѧpaperµÄ¼ÛÖµÎÊÌ⣬Çó´ïÈ˰ïæ
ÒѾÓÐ7È˻ظ´
Çë´ïÈ˰ïæ¿´Ò»Ï£¬±à¼ÈçϵľܸåÀíÓÉÄÜ·ñdebateÒ»ÏÂ
ÒѾÓÐ6È˻ظ´
¡¾ÌÖÂÛ¡¿Çë½Ì´ïÈË£º»ìºÏ±íÃæ»îÐÔ¼ÁµÄŨÈÜҺΪʲôºÜÈÝÒ×»á½áƤ£¿
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú¡¿Ïò¸÷λǰ±²´ïÈËÇë½Ì»§¿ÚÎÊÌâ
ÒѾÓÐ10È˻ظ´
¶ÔÓÚÒ»¾ä»°µÄÀí½â~~´ïÈ˰ï°ï棡£¡£¡
ÒѾÓÐ3È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿16s½ø»¯Ê÷+ϸ¾ú¼ø¶¨ ´ïÈË Çë½ø~~~
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿ÇëÎʸ÷λʳƷ´ïÈË£¬Ë®ÖÐ×ܴ󳦾úȺÈçºÎ²â¶¨£¿
ÒѾÓÐ8È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
¸£½¨Ê¦·¶´óѧҶӦÏé¿ÎÌâ×éÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú
+2/170
¼ÓÄô󰢶û²®Ëþ´óѧÕÐÊÕµç´Å¡¢ÎÞÏßͨÐÅ¡¢»úÆ÷ѧϰ·½ÏòÈ«½±Ë¶Ê¿/²©Ê¿/²©Ê¿ºó/·ÃÎÊѧÕß
+1/53
0854µç×ÓÐÅÏ¢µ÷¼Á£¬ÃöÄÏʦ´ó¹âµçоƬÑз¢ÊµÑéÊÒ£¬¿ÂÉÙÓ±½ÌÊÚ¿ÎÌâ×飬¼¯³Éµç·
+1/36
ÉϺ£½»Í¨´óѧµç´ß»¯·½Ïò²©ºóÕÐÆ¸-ÓÐ﮵硢¸ß·Ö×Ó¡¢È¼ÁÏµç³Ø±³¾°ÕßÓÅÏÈ
+1/31
---´óÁäµÄδ»éÄÐÕÒ½á»éÅ®¶ÔÏó
+1/18
¡¾Ô¤Ë¶¡¿¡¾Ô¤²©¡¿Çൺ´óѧÉúÎïÒ½Ò©´´ÐÂת»¯
+1/15
2026ÄêÎ÷ÄϿƼ¼´óѧ¹¦ÄÜÍ¿²ã¿ÎÌâ×é¼ò½é
+1/10
ÉîÛÚÐÅÏ¢Ö°Òµ´óѧÕÐÆ¸ÁªºÏÅàÑøË¶²©Ñо¿Éú£¨¼±£©
+1/10
ÐÂ¼ÓÆÂ¹úÁ¢´óѧҩѧϵ»¯Ñ§ÉúÎïѧ¿ÎÌâ×éÕÐPhD
+1/7
211/˫һÁ÷---ʯºÓ×Ó´óѧ---Óлú»¯Ñ§·½ÏòÕе÷¼ÁÉú
+1/7
¡¾¿ÆÑиɻõ¡¿ÄÉÃ׿¹ÌåÆ¾Ê²Ã´³ÉΪʵÑéÊÒ¡°Ð³衱£¿¸½ÓÅÖÊÖÆ±¸·þÎñÉ̲ο¼
+1/7
Çൺ¿Æ¼¼´óѧ¿É³ÖÐø¸ß·Ö×ÓÍÅ¶Ó ¿¼ÑÐÕÐÉú
+1/6
¸£ÖÝ´óѧ¹ú¼Ò¼¶È˲ÅÌÀÓýÐÀ½ÌÊÚ¿ÎÌâ×é2026ÄêÕÐÊÕ¡±ÉêÇ뿼ºËÖÆ¡°´¢ÄÜµç³Ø·½Ïò²©Ê¿Ñо¿Éú
+1/6
˫һÁ÷˶ʿÕÐÉúÐÅÏ¢
+1/5
Çóµ÷¼Á£üÒ»Ö¾Ô¸¹ã¶«¹¤Òµ´óѧ¿ØÖƹ¤³Ì£ü×Ü·Ö355£ü±¾¿ÆµçÆø£üÓÐÏîÄ¿/¾ºÈü/ÂÛÎľÀú
+1/3
0854µ÷¼Á£¬Ò»Ö¾Ô¸¹ú¿Æ´ó£¬22408£¬½ÓÊÜ¿çרҵ
+1/3
125603¹¤Òµ¹¤³ÌÓë¹ÜÀíµ÷¼Á
+1/1
¹ú¼Ò½ÜÇàµÍά²ÄÁÏÓëÆ÷¼þÁ¦Ñ§ÍŶÓ2026ÄêÕÐÊÕ²©Ê¿Ñо¿Éú
+1/1
Î人ÇṤ´óѧÍÁľˮÀûÇཷ˶µ¼Õе÷¼Á
+1/1
Õã½´óѧ¸ß´¿·ÖÀëÍÅ¶Ó³ÏÆ¸²©Ê¿ºó
+1/1
¡ï
qinjysdu(½ð±Ò+2):лл²ÎÓë
qinjysdu(½ð±Ò+5):лл£¬¸Ã·½·¨Ó¦¸Ã¿ÉÐУ¡ 2010-12-08 08:29:19
qinjysdu(½ð±Ò+2):лл²ÎÓë
qinjysdu(½ð±Ò+5):лл£¬¸Ã·½·¨Ó¦¸Ã¿ÉÐУ¡ 2010-12-08 08:29:19
| ²»ÖªµÀ²î¼õÔÓ½»ÊDz»ÊÇ¿ÉÒÔ |
4Â¥2010-12-07 23:34:29
xp198766
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- MolEPI: 1
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 6525.1
- Ìû×Ó: 2193
- ÔÚÏß: 554Сʱ
- ³æºÅ: 1046859
¡ï
qinjysdu(½ð±Ò+2):лл²ÎÓë
qinjysdu(½ð±Ò+2):лл£¬Õâ¸ö·½·¨¾ÍÅÂ×Ô¼ºÕÒ³öµÄ¿ÉÄܵĻùÒòûÓаüº¬Êµ¼ÊµÄ²îÒì»ùÒò£¡ 2010-12-08 08:30:35
qinjysdu(½ð±Ò+2):лл²ÎÓë
qinjysdu(½ð±Ò+2):лл£¬Õâ¸ö·½·¨¾ÍÅÂ×Ô¼ºÕÒ³öµÄ¿ÉÄܵĻùÒòûÓаüº¬Êµ¼ÊµÄ²îÒì»ùÒò£¡ 2010-12-08 08:30:35
| ¿É²»¿ÉÒÔÔÚ¿¹ÄæÌõ¼þÏÂÌáRNA£¬ÕÒЩ¿ÉÄܵĻùÒò×öqPCR¿´¿´~~~~ |
3Â¥2010-12-07 22:33:42
wangleisdnu
½ð³æ (ÕýʽдÊÖ)
- MolEPI: 2
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ¹ó±ö: 0.001
- ½ð±Ò: 992.2
- Ìû×Ó: 407
- ÔÚÏß: 131.3Сʱ
- ³æºÅ: 89944
¡ï ¡ï ¡ï
qinjysdu(½ð±Ò+2):лл²ÎÓë
rainwander(½ð±Ò+2):¹ÄÀø»ý¼«²ÎÓë~ 2010-12-08 08:15:07
qinjysdu(½ð±Ò+2):лл²ÎÓë
rainwander(½ð±Ò+2):¹ÄÀø»ý¼«²ÎÓë~ 2010-12-08 08:15:07
|
Non-radioactive RNA fingerprint procedure First strand cDNA synthesis was performed with 15 mg of total RNA, 500 pmol oligo(dT)18 and 800U Superscript II reverse transcriptase (Life Technologies) in a volume of 100ml RT buffer, following the manufacturer¡¯s instructions. After heat inactivation of reverse transcriptase and RNase A digestion, reaction products were purified from excess oligonucleotides by using a QIAquick kit (Qiagen). cDNA derived from 75 ng of total RNA was used as template for PCR. Amplification was performed in 20 ml of PCR buffer (10mM Tris-Cl pH 8.3, 50mM KCl, 1.5mM MgCl2) with 125mM dNTPs (Pharmacia) and 1mM each primer. For each reaction, two 18-mer oligonucleotides, of arbitrary sequence and a GC content of 61%, were used. Sequences of all 131 oligonucleotides used in this screen can be obtained upon request. All PCR amplifications were performed on an Omni-Gene thermal cycler (Hybaid). After 2 min of denaturation at 948C, 2 units of Taq DNA polymerase (Roche) were added (manual ¡®hot start¡¯). After 1 min at 948C, the profile was started with two, low-stringency cycles (948C for 1.5 min, 508C for 3.5 min and 728C for 3 min) followed by 35¨C40 high-stringency cycles (948C for 1 min, 658C for 1 min, and 728C for 1 min), and a final 5 min extension at 728C. Reaction products were separated on 2% SeaKem LE agarose gels (FMC) for 3.5 h at 6¨C 7Vcm21 and 88C. Gel and running buffer was 0.5X TBE (50mM Tris-borate pH 7.9, 1mM Na2-EDTA) containing 5mgml21 ethidium bromide. Bands of interest were excised, DNA was eluted with a Jetsorb kit (Genomed) and the amplicons were cloned directly by using a Topo TA cloning kit (Invitrogen). ÕâÖÖ·½·¨±È½ÏµÄÔʼ£¬Ó¦¸Ã±È½ÏµÄ±ãÒË |
5Â¥2010-12-08 04:32:53
6Â¥2010-12-08 08:33:07













»Ø¸´´ËÂ¥